Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David C. Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Jeffrey L. Dage, Oskar Hansson
doi: https://doi.org/10.1101/2020.01.15.20017236
Shorena Janelidze
1Clinical Memory Research Unit, Lund University, Lund, Sweden
PhDErik Stomrud
1Clinical Memory Research Unit, Lund University, Lund, Sweden
Ruben Smith
1Clinical Memory Research Unit, Lund University, Lund, Sweden
2Department of Neurology, Skåne University Hospital, Lund, Sweden
PhD, MDSebastian Palmqvist
1Clinical Memory Research Unit, Lund University, Lund, Sweden
2Department of Neurology, Skåne University Hospital, Lund, Sweden
PhD, MDNiklas Mattsson
1Clinical Memory Research Unit, Lund University, Lund, Sweden
2Department of Neurology, Skåne University Hospital, Lund, Sweden
3Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden
PhD, MDDavid C. Airey
4Eli Lilly and Company, Indianapolis IN 46285 U.S.A.
PhDNicholas K. Proctor
4Eli Lilly and Company, Indianapolis IN 46285 U.S.A.
BSXiyun Chai
4Eli Lilly and Company, Indianapolis IN 46285 U.S.A.
MDSergey Shcherbinin
4Eli Lilly and Company, Indianapolis IN 46285 U.S.A.
PhDJohn R. Sims
4Eli Lilly and Company, Indianapolis IN 46285 U.S.A.
MDJeffrey L. Dage
4Eli Lilly and Company, Indianapolis IN 46285 U.S.A.
PhDOskar Hansson
1Clinical Memory Research Unit, Lund University, Lund, Sweden
5Memory Clinic, Skåne University Hospital, Malmö, Sweden
MD, PhDData Availability
Anonymized data will be shared by request from any qualified investigator for the sole purpose of replicating procedures and results presented in the manuscript and as long as data transfer is in agreement with EU legislation on the general data protection regulation (GDPR).
Posted January 16, 2020.
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David C. Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Jeffrey L. Dage, Oskar Hansson
medRxiv 2020.01.15.20017236; doi: https://doi.org/10.1101/2020.01.15.20017236
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David C. Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Jeffrey L. Dage, Oskar Hansson
medRxiv 2020.01.15.20017236; doi: https://doi.org/10.1101/2020.01.15.20017236
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12766)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4600)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (926)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4377)
- Nursing (237)
- Nutrition (640)
- Oncology (2278)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1533)
- Respiratory Medicine (916)
- Rheumatology (441)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)